Cargando…
Intellectual property and access to medicines: mapping public attitudes toward pharmaceuticals during the United States-Mexico-Canada Agreement (USMCA) negotiation process
BACKGROUND: Transparency and accountability are essential components at all stages of the trade negotiation process. This study evaluates the extent to which these principles were upheld in the United States’ public consultation process during the negotiation of the United States-Mexico-Canada Agree...
Autores principales: | Wong, Anna S. Y., Cole, Clarke B., Kohler, Jillian C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379891/ https://www.ncbi.nlm.nih.gov/pubmed/34416883 http://dx.doi.org/10.1186/s12992-021-00740-1 |
Ejemplares similares
-
Negotiating public-health intellectual property licensing agreements to increase access to health technologies: an insider’s story
por: Gore, Charles, et al.
Publicado: (2023) -
USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health
por: Labonté, Ronald, et al.
Publicado: (2019) -
Correction to: USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health
por: Labonté, Ronald, et al.
Publicado: (2019) -
USMCA 2.0: a few improvements but far from a ‘healthy’ trade treaty
por: Labonté, Ronald, et al.
Publicado: (2020) -
Should Canada adopt managed access agreements in Canada for expensive drugs?
por: McPhail, Melanie, et al.
Publicado: (2023)